{
  "meta": {
    "title": "00124_Mid_Day_Module_Pyqs_Mixed_Bag-21",
    "url": "https://brainandscalpel.vercel.app/00124-mid-day-module-pyqs-mixed-bag-21-2bdaac31.html",
    "scrapedAt": "2025-11-29T18:13:12.002Z"
  },
  "questions": [
    {
      "id": 50954,
      "choices": [
        {
          "id": 203357,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest wall neuromuscular disease&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203358,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203359,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic pulmonary fibrosis&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203360,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchiectasis&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows a normal graph on the left and the patient&#39;s graph on the right. Which of the following diagnoses can be inferred from the graph? (</span></span></span></span>INICET Nov 2023)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-112354.png\" style=\"height:188px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q8251401",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510008,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchiectasis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The spirometry graph compares a normal patient&#39;s lung function with that of the patient. The normal graph shows an FEV1/FVC ratio (Forced Expiratory Volume in 1 second / Forced Vital Capacity) of more than 70%, which is typical in healthy individuals. In contrast, the patient&#39;s graph shows a significantly reduced FEV1/FVC ratio of approximately 50-55%, indicating an obstructive lung disease. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive lung diseases are characterized by reduced airflow due to airway narrowing or obstruction, leading to a lower FEV1/FVC ratio. The common obstructive lung diseases include asthma, emphysema, chronic bronchitis, COPD, bronchiectasis, and cystic fibrosis. Among the given options, bronchiectasis is the only obstructive lung disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Chest wall neuromuscular disease:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This typically causes restrictive lung disease, not obstructive, and would present with a normal or high FEV1/FVC ratio but reduced lung volumes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sarcoidosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is an interstitial lung disease, which is restrictive. It would show a normal or elevated FEV1/FVC ratio with reduced lung volumes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Idiopathic pulmonary fibrosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Another interstitial lung disease leading to restrictive patterns on spirometry, characterized by a normal or high FEV1/FVC ratio with reduced total lung capacity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A reduced FEV1/FVC ratio (&lt;70%) is indicative of obstructive lung disease. Among the given options, bronchiectasis is the obstructive lung disease associated with this spirometry pattern.</span></span></p>",
      "correct_choice_id": 203360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20921,
      "choices": [
        {
          "id": 83648,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3 deficiency</span></p>"
        },
        {
          "id": 83649,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B1 deficiency</span></p>"
        },
        {
          "id": 83650,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B6 deficiency</span></p>"
        },
        {
          "id": 83651,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with diarrhea, dermatitis, and dementia. Which of the following vitamin deficiencies would you suspect in this patient?&nbsp;</span>(NEET PG 2023)</p>",
      "unique_key": "Q6554705",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510013,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin B3 deficiency</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of a patient with diarrhea, dermatitis, and dementia is suggestive of niacin/vitamin B3 deficiency. Vitamin B3 (also called niacin, nicotinic acid)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Vitamin B1/Thiamine deficiency</strong></span><span style=\"font-size:12pt;\"><strong>:</strong></span><strong>&nbsp;</strong><span style=\"font-size:12.0pt;\">can manifest as wet beriberi (CVS features like heart failure and edema), dry beriberi (peripheral neuritis), or as Wernicke encephalopathy with Korsakoff psychosis (in alcoholics). Dietary deficiency of thiamine inhibits pyruvate dehydrogenase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Vitamin B6/Pyridoxine deficiency:</strong></span><strong> </strong><span style=\"font-size:12.0pt;\">causes Convulsions, hyperirritability, peripheral neuropathy (deficiency inducible by isoniazid and oral contraceptives), sideroblastic anemia (due to impaired hemoglobin synthesis and iron excess)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Vitamin B12/Cobalamin deficiency:</strong></span><strong> </strong><span style=\"font-size:12.0pt;\">causes Macrocytic, megaloblastic anemia, paraesthesia and subacute combined degeneration due to abnormal myelin. Associated with</span></p><p><span style=\"font-size:12.0pt;\">↑ serum homocysteine and methylmalonic acid levels, along with 2° folate deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-01-182602.jpg\" alt=\"\" width=\"1000\" height=\"504\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Following image shows Casal’s Necklace &amp; hyperpigmentation of sun-exposed limbs:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-01-182659.jpg\" alt=\"\" width=\"350\" height=\"526\"></span></p>",
      "correct_choice_id": 83648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12825,
      "choices": [
        {
          "id": 51262,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 4 only </span></span></span></p>"
        },
        {
          "id": 51263,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3 and 4 </span></span></span></p>"
        },
        {
          "id": 51264,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3 and 5 </span></span></span></p>"
        },
        {
          "id": 51265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3, 4 and 5 </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A skull was recovered from a forest. According to inquest papers, woman had gone missing after a fight with her boyfriend a month back. The skull was sent to the forensic research lab. Which of the following would identify it as a female skull? (</span></span></span>INICET May 2021)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Large frontal and parietal eminence</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Heavy cheek bones</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Smooth glabella</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Square orbits</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Narrow mastoid</span></span></span></li>\r\n</ol>",
      "unique_key": "Q8785048",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509762,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C. 1, 3 and 5&nbsp; </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Female Skull Characteristics:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Large frontal and parietal eminence:</span></strong><span style=\"font-size:12.0pt\"> These are more prominent in females.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. Smooth glabella:</span></strong><span style=\"font-size:12.0pt\"> Females typically have a smoother glabella compared to males.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">5. Narrow mastoid:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Female mastoid processes are generally narrower and less prominent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These characteristics help in identifying the skull as female.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Note - </span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">General&nbsp;</span></span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">differences between male and female bones:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">There are some general features which help to differentiate male and female bones. These are</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Size:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male bones are larger than female bones.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Roughness:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male bones are more rougher due to increased muscle attachment areas. Females have smooth features</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Weight:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male bones are heavier than female bones</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Articular Surface Size:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male bones may have larger articular surfaces compared to females</span></span></span><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">.</span></span></span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Square features:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Male have square features, whereas females have rounded features</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">So for individual bones, just remember the specific features, instead of general features</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">Other Options</span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Heavy cheek bones</span></strong><span style=\"font-size:12.0pt\">: Typical in males, as a general rule, female bones are lighter than male bones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:#fcfcff\"><span style=\"color:black\">4. </span></span></span></strong><strong><span style=\"font-size:12.0pt\">Square orbits:</span></strong><span style=\"font-size:12.0pt\"> Males have squarish features, whereas females have roundish features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most features are larger, rougher, and more prominent in male skull, except frontal eminence, parietal eminence and orbits which are more prominent or larger in females</span></span></span></p>",
      "correct_choice_id": 51264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55765,
      "choices": [
        {
          "id": 222493,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3 months</span></span></span></p>"
        },
        {
          "id": 222494,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">9 months</span></span></span></p>"
        },
        {
          "id": 222495,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">15 months</span></span></span></p>"
        },
        {
          "id": 222496,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">18 months</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A pediatric surgeon is planning the optimal timing for cleft palate surgery on a young patient. For the repair of the soft palate, at what age should the surgery ideally be performed? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q5779993",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510010,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 3 months</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Soft palate repair is typically performed between <strong>3 to 6 months of age</strong>. This early intervention is crucial as it facilitates better outcomes in terms of speech development and minimizes the risks associated with feeding difficulties. Early repair allows for more normal development of speech patterns as the child grows, which is vital for effective communication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The timing of cleft palate surgery &ndash; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For the soft palate, surgery is ideally conducted at 3 -6 months </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For the hard palate repair is done at 12-15 months.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 222493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54940,
      "choices": [
        {
          "id": 219221,
          "text": "<p><span style=\"font-size:12.0pt;\">Pox virus</span></p>"
        },
        {
          "id": 219222,
          "text": "<p><span style=\"font-size:12.0pt;\">CMV</span></p>"
        },
        {
          "id": 219223,
          "text": "<p><span style=\"font-size:12.0pt;\">EBV</span></p>"
        },
        {
          "id": 219224,
          "text": "<p><span style=\"font-size:12.0pt;\">Chickenpox</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old patient on immunosuppressive therapy presents with cough, fever, and pneumonia. A biopsy reveals the cells shown in the image. Which organism is responsible for this finding? (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/27/5_6228736506677170931.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p>",
      "unique_key": "Q3186967",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509761,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) CMV (Cytomegalovirus)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image provided shows cells with the characteristic \"owl eye\" appearance, which is a classic histopathological finding in infections caused by Cytomegalovirus (CMV). CMV is a type of herpesvirus that can cause severe infections, especially in immunocompromised patients, such as those on immunosuppressive therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"owl eye\" appearance refers to the large intranuclear inclusion bodies surrounded by a clear halo, resembling an owl's eye. This appearance is due to the replication of the virus within the nucleus of the infected cell, leading to the formation of these inclusion bodies. <strong>In CMV infections, both intranuclear and intracytoplasmic basophilic inclusions can be observed, which is a key diagnostic feature.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CMV commonly causes pneumonia in immunocompromised individuals, such as those with HIV/AIDS, organ transplant recipients, or patients on immunosuppressive therapy. The virus can also cause other severe complications, including retinitis, colitis, and encephalitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note – <strong>Ganciclovir - </strong>Preferred antiviral medication for treating CMV infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pox virus:</strong> Poxviruses, such as the variola virus (which causes smallpox), typically produce skin lesions and are not known for causing the \"owl eye\" appearance in cells. Therefore, this option is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. EBV (Epstein-Barr Virus):</strong> EBV is associated with conditions such as infectious mononucleosis and certain lymphomas, like Burkitt's lymphoma. It does not typically produce the \"owl eye\" inclusions seen in CMV infection, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chickenpox (Varicella-Zoster Virus):</strong> Chickenpox, caused by the varicella-zoster virus, is characterized by vesicular skin lesions and does not produce the \"owl eye\" appearance in histological sections. Therefore, this option is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"owl eye\" appearance of cells in a biopsy is a hallmark of Cytomegalovirus (CMV) infection, particularly in immunocompromised patients. This feature is crucial for diagnosing CMV-related complications, such as CMV pneumonia.</span></p>",
      "correct_choice_id": 219222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4553,
      "choices": [
        {
          "id": 18188,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrograffin</span></p>"
        },
        {
          "id": 18189,
          "text": "<p><span style=\"font-size:12.0pt;\">lohexol</span></p>"
        },
        {
          "id": 18190,
          "text": "<p><span style=\"font-size:12.0pt;\">Gadolinium</span></p>"
        },
        {
          "id": 18191,
          "text": "<p><span style=\"font-size:12.0pt;\">Barium sulphate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the best contrast agent for the diagnosis of esophageal perforation?&nbsp;</span>(NEET PG 2018)</p>",
      "unique_key": "Q8596419",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510003,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Iohexol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Barium contrast is contraindicated</strong> <strong>in esophageal perforation</strong> as it causes mediastinitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Iodinated contrast is safe&nbsp;</strong>for suspected GI perforation or trachea-esophageal fistula where barium is contraindicated. <strong>Iohexol (low osmolar) is preferred over Gastrograffin (high-osmolar)</strong> as it has a high chance of causing aspiration pneumonitis and pulmonary edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gastrograffin: </strong>While also iodine-based and water-soluble, Gastrograffin is a high-osmolar contrast agent that can be riskier in cases of perforation due to the potential for causing severe pulmonary complications if aspirated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gadolinium: </strong>Gadolinium is primarily used in magnetic resonance imaging (MRI) and is not suitable for gastrointestinal tract imaging, especially in the context of suspected perforations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Barium sulphate: </strong>Although providing high-quality imaging, barium sulphate is contraindicated in cases of suspected perforations due to its potential to cause severe inflammatory reactions if it escapes into the mediastinal or pleural spaces.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_188.jpg\" alt=\"\" width=\"900\" height=\"611\"></span></p>",
      "correct_choice_id": 18189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10310,
      "choices": [
        {
          "id": 41206,
          "text": "<p><span style=\"font-size:12.0pt;\">About 20-30% of the infections are symptomatic</span></p>"
        },
        {
          "id": 41207,
          "text": "<p><span style=\"font-size:12.0pt;\">Triad of SNHL, periventricular calcification and enamel hypoplasia</span></p>"
        },
        {
          "id": 41208,
          "text": "<p><span style=\"font-size:12.0pt;\">Most children asymptomatic at birth can develop conductive hearing loss later in life</span></p>"
        },
        {
          "id": 41209,
          "text": "<p><span style=\"font-size:12.0pt;\">If mother is IgG positive for CMV, the child is unlikely to develop infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a true statement about congenital CMV infection? (INICET MAY 2021)</span></p>",
      "unique_key": "Q3988594",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509776,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) If mother is IgG positive for CMV, the child is unlikely to develop infection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Congenital cytomegalovirus (CMV) infection is a significant cause of congenital infection and can lead to a range of outcomes in the fetus, depending on the timing and nature of maternal infection. If a mother is IgG positive for CMV, it indicates a past infection and a lower risk of transmitting the virus to the fetus compared to a primary infection. This is because maternal IgG antibodies can provide some protection to the fetus. However, there remains a small risk of reactivation of the virus or reinfection during pregnancy, which could lead to congenital CMV infection in the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. About 20-30% of the infections are symptomatic:&nbsp;</strong>About 20-30% of the infections are symptomatic is incorrect because the correct percentage of symptomatic congenital CMV infections at birth is about 10%, not 20-30%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Triad of SNHL, periventricular calcification and enamel hypoplasia</strong>: Triad of SNHL, periventricular calcification and enamel hypoplasia is incorrect because enamel hypoplasia is not a typical part of the triad for congenital CMV infection. The common findings include SNHL, periventricular calcifications, and developmental delays.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Most children asymptomatic at birth can develop conductive hearing loss later in life</strong>: Most children asymptomatic at birth can develop conductive hearing loss later in life is incorrect because asymptomatic infants at birth are less likely to develop hearing loss, and if they do, it is usually sensorineural, not conductive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Maternal IgG positivity for CMV suggests a lower risk of congenital CMV transmission, making it less likely for the fetus to develop the infection.</span></p>",
      "correct_choice_id": 41209,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54282,
      "choices": [
        {
          "id": 216597,
          "text": "<p><span style=\"font-size:12.0pt;\">Mifepristone</span></p>"
        },
        {
          "id": 216598,
          "text": "<p><span style=\"font-size:12.0pt;\">Cabergoline</span></p>"
        },
        {
          "id": 216599,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorpromazine</span></p>"
        },
        {
          "id": 216600,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman, having lost her newborn, is producing breast milk, which risks developing into a breast abscess due to milk stasis and incomplete emptying. Which drug can prevent this complication?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7693853",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509767,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Cabergoline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this scenario, the primary goal is to suppress lactation to prevent milk stasis and subsequent breast abscess formation. Lactation is driven by the hormone prolactin, which is released from the anterior pituitary gland. To suppress milk production, prolactin release must be inhibited.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cabergoline is a dopamine receptor agonist that works by stimulating dopamine receptors, which in turn inhibits prolactin secretion from the anterior pituitary gland. By reducing prolactin levels, cabergoline effectively suppresses lactation, thereby reducing the risk of milk stasis and breast abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mifepristone:</strong> This drug is a progesterone receptor antagonist primarily used for medical termination of pregnancy. It does not have a role in suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chlorpromazine:</strong> This is an antipsychotic medication that blocks dopamine D2 receptors. Blocking dopamine receptors would actually increase prolactin levels and promote milk production, thus potentially worsening the risk of milk stasis and abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metoclopramide:</strong> This drug is a dopamine D2 receptor antagonist and is sometimes used as a galactagogue (to promote milk production). Like chlorpromazine, it would increase prolactin levels and thus is not suitable for preventing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cabergoline, a dopamine receptor agonist, is used to suppress lactation by inhibiting prolactin secretion, thereby preventing complications like milk stasis and breast abscess.</span></p>",
      "correct_choice_id": 216598,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55389,
      "choices": [
        {
          "id": 221017,
          "text": "<p><span style=\"font-size:12pt;\">PCT</span></p>"
        },
        {
          "id": 221018,
          "text": "<p><span style=\"font-size:12pt;\">DCT</span></p>"
        },
        {
          "id": 221019,
          "text": "<p><span style=\"font-size:12pt;\">Loop of Henle</span></p>"
        },
        {
          "id": 221020,
          "text": "<p><span style=\"font-size:12pt;\">Collecting duct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Where does the maximum water absorption occur within the renal tubules? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q3841129",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510002,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) PCT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Proximal Convoluted Tubule (PCT) is the site where the majority of water reabsorption occurs in the nephron. Approximately 60-65% of the filtered water is reabsorbed in the PCT. This reabsorption is largely due to the active transport of sodium ions, which creates an osmotic gradient that drives water reabsorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The PCT is highly efficient in reclaiming water, electrolytes, and other essential nutrients from the filtrate, ensuring that the body retains vital substances while excreting waste products.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>DCT (Distal Convoluted Tubule):&nbsp;</strong> While the DCT does participate in water reabsorption, it does so to a much lesser extent compared to the PCT. The DCT is more involved in the fine-tuning of sodium, potassium, and pH balance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Loop of Henle:&nbsp;</strong> The Loop of Henle, particularly the descending limb, is permeable to water and contributes to water reabsorption. However, the amount of water reabsorbed here is significantly less than in the PCT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Collecting duct: </strong>The collecting duct is involved in the final concentration of urine and reabsorption of water under the influence of antidiuretic hormone (ADH). While it plays a crucial role in water reabsorption, the total volume reabsorbed here is less than in the PCT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Proximal Convoluted Tubule (PCT) is the site of maximum water absorption within the renal tubules, reabsorbing about 60-65% of the filtered water.</span></p>",
      "correct_choice_id": 221017,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52808,
      "choices": [
        {
          "id": 210721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis</span></span></span></p>"
        },
        {
          "id": 210722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Poststreptococcal glomerulonephritis</span></span></span></p>"
        },
        {
          "id": 210723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
        },
        {
          "id": 210724,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IgA nephropathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A woman presents to you with fever, arthralgia, ulcers, fatigue for the past six months, and new-onset hematuria. Urine examination reveals RBC casts and proteinuria. What is the likely diagnosis? (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q3984765",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509756,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C. Lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is a common complication of systemic lupus erythematosus (SLE), an autoimmune disease that can affect multiple organ systems. The patient&#39;s symptoms of fever, arthralgia, ulcers, and fatigue, combined with new-onset hematuria and findings of RBC casts and proteinuria in the urine, are indicative of systemic involvement typical of lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is characterized by inflammation of the kidneys, often leading to hematuria, proteinuria, and renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Next Step -</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Conducting an ANA (antinuclear antibody) test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Performing an anti-dsDNA (anti-double stranded DNA) test, which is noted as being very specific and correlates with lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Acute interstitial nephritis:</span></strong><span style=\"font-size:12.0pt\"> This condition typically presents with WBC casts rather than RBC casts in the urine and is not usually associated with systemic symptoms like fever, arthralgia, or ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Poststreptococcal glomerulonephritis (PSGN):</span></strong><span style=\"font-size:12.0pt\"> While PSGN can cause RBC casts and proteinuria, it is generally a renal-limited condition and does not present with systemic symptoms like fever, arthralgia, and ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. IgA nephropathy:</span></strong><span style=\"font-size:12.0pt\"> IgA nephropathy is also a renal-limited condition and typically does not present with systemic symptoms. It is characterized by recurrent episodes of gross hematuria, usually following upper respiratory infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus nephritis should be suspected in patients with systemic lupus erythematosus who present with renal symptoms such as hematuria and proteinuria, especially when accompanied by systemic symptoms like fever, arthralgia, ulcers, and fatigue. Further testing, including ANA and anti-dsDNA antibodies, is warranted to confirm the diagnosis.</span></span></p>",
      "correct_choice_id": 210723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10261,
      "choices": [
        {
          "id": 41010,
          "text": "<p><span style=\"font-size:18px;\">Use MR vaccine and discard pentavalent vaccine</span></p>"
        },
        {
          "id": 41011,
          "text": "<p><span style=\"font-size:18px;\">Use pentavalent vaccine and discard MR vaccine</span></p>"
        },
        {
          "id": 41012,
          "text": "<p><span style=\"font-size:18px;\">Use both</span></p>"
        },
        {
          "id": 41013,
          "text": "<p><span style=\"font-size:18px;\">Discard both</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>An auxiliary nurse midwife is tasked with organizing a vaccination camp within a rural community. She has been provided with 2 vials that have been unsealed. Among these, one contains a pentavalent vaccine, while the other holds an MR vaccine. What options does she have in terms of effectively using these vials?</strong><i><strong> [NEET PG 2022]</strong></i></span></p>",
      "unique_key": "Q1138432",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510015,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Use pentavalent vaccine and discard MR vaccine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">According to the Open Vial Policy, certain vaccines can be used for subsequent sessions for up to 4 weeks after opening, provided they have been stored properly and are not expired. This policy helps to minimize vaccine wastage and ensure efficient use of available vaccines.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Open Vial Policy (2015)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Opened vaccine vials can be used in subsequent session ‘UPTO 4 WEEKS’</span></li><li><span style=\"color:black;font-size:18px;\">Open vial policy –&nbsp;</span><ul><li><span style=\"color:black;font-size:18px;\">Applicable for - Hep B, OPV, DPT, Liquid pentavalent, TT, PCV, IPV, HiB</span></li><li><span style=\"color:black;font-size:18px;\">Not applicable for - BCG, MR, JE, RVV, Covid-19 vaccines</span></li></ul></li><li><span style=\"font-size:18px;\">Expiry date should not pass, VVM within usability limits, Cold chain maintenance</span></li><li><span style=\"font-size:18px;\">Vaccine vial septum not submerged in water or contaminated, Aseptic technique used to withdraw doses</span></li><li><span style=\"font-size:18px;\">Record date and time of each vial opening</span></li><li><span style=\"font-size:18px;\">At end of session return all open vials to Cold chain:</span><ul><li><span style=\"font-size:18px;\">Reusable open vials: DPT, DT, Hepatitis B, Pentavalent</span></li><li><span style=\"font-size:18px;\">Non-reusable open vials: Measles, BCG, JE (Destroy after 48 hours or Next session whichever earlier)</span></li><li><span style=\"font-size:18px;\">If any AEFI reported: Store all vials in Cold chain till completion of investigation</span></li></ul></li></ul><p style=\"margin-left:15px;\">&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Under the Open Vial Policy, the auxiliary nurse midwife can use the pentavalent vaccine for subsequent sessions up to 4 weeks after opening, but must discard the MR vaccine as it does not fall under the Open Vial Policy.</span></p>",
      "correct_choice_id": 41011,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24708,
      "choices": [
        {
          "id": 98793,
          "text": "<p><span style=\"font-size:12pt;\">Hemangioma</span></p>"
        },
        {
          "id": 98794,
          "text": "<p><span style=\"font-size:12pt;\">Cystic hygroma</span></p>"
        },
        {
          "id": 98795,
          "text": "<p><span style=\"font-size:12pt;\">Branchial cyst</span></p>"
        },
        {
          "id": 98796,
          "text": "<p><span style=\"font-size:12pt;\">Ranula</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the following image: </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/13.jpg\" alt=\"\" width=\"300\" height=\"261\"></span></p>",
      "unique_key": "Q8875736",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510014,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ranula</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario and the image showing a cystic swelling on the floor of the mouth points to a diagnosis of a Ranula.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/ranula.jpg\" alt=\"\" width=\"1000\" height=\"1262\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hemangioma</strong>: A benign tumor made up of blood vessels, often appearing as a birthmark or red growth.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cystic hygroma</strong>: A fluid-filled sac that results from a blockage in the lymphatic system, often present at birth. It presents as a posterior neck swelling.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Branchial cyst</strong>: A congenital epithelial cyst that arises from remnants of the branchial arches, usually presenting as a neck lump.</span></p>",
      "correct_choice_id": 98796,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55645,
      "choices": [
        {
          "id": 222025,
          "text": "<p><span style=\"font-size:12.0pt;\">Langerhans cell histiocyotsis&nbsp;</span></p>"
        },
        {
          "id": 222026,
          "text": "<p><span style=\"font-size:12.0pt;\">Paget's disease</span></p>"
        },
        {
          "id": 222027,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperparathyroidism</span></p>"
        },
        {
          "id": 222028,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient present with Cotton wool skull. Most likely diagnosis is: (FMGE JULY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110143.jpg\" width=\"413\" height=\"338\"></span></p>",
      "unique_key": "Q1126823",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509775,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Paget's disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Paget's disease of bone, also known as <strong>osteitis deformans</strong>, is a <strong>chronic disorder</strong> that can result in <strong>enlarged and misshapen bones</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">The condition is named after Sir James Paget, who first described it.&nbsp;</span></li><li><span style=\"font-size:16px;\">The <strong>\"cotton wool\" appearance of the skull is a radiological hallmark</strong> of Paget's disease, resulting from the <strong>irregular thickening and softening of the bone</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\">This appearance is due to a <strong>chaotic remodelling</strong> process where <strong>excessive bone resorption</strong> is followed by <strong>disorganized bone formation</strong>.</span></li><li><span style=\"font-size:16px;\">Thus, the skull X-ray reveal “cotton wool” or <strong>osteoporosis circumscripta</strong>, thickening of diploic area.&nbsp;<strong>Increasing Hat Size!</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-24%20110158.jpg\" width=\"855\" height=\"390\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Additional Information:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/4444666_Page_1.jpg\" width=\"1384\" height=\"1937\"></strong></span></p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/4444666_Page_2.jpg\" width=\"1390\" height=\"1415\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"color:black;font-size:16px;\"><strong>Option A. Langerhans cell histiocyotsis:&nbsp;</strong>The radiological imaging of the skull in Langerhans cell histiocytosis shows&nbsp;solitary or multiple punched-out lytic lesions without sclerotic rim;&nbsp;double contour or beveled edge appearance due to asymmetrical involvement of the inner and outer; button sequestrum&nbsp;representing residual bone; and geographic skull.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Hyperparathyroidism:&nbsp;</strong></span><span style=\"background-color:white;color:black;font-size:16px;\"><strong>Salt and pepper sign&nbsp;</strong>due to multiple tiny well-defined lucencies in the calvaria caused by resorption of trabecular bone in&nbsp;hyperparathyroidism. There is a loss of definition between the inner and outer tables of the skull; a ground-glass appearance; and spotty deossification.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Multiple myeloma:&nbsp;</strong>Radiographically, multiple myeloma appears as multiple, “punched-out”, sharply demarcated, purely lytic lesions without any surrounding reactive sclerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The \"cotton wool\" appearance of the skull on radiographs is a classic sign of Paget's disease.&nbsp;</span></li><li><span style=\"font-size:16px;\">This pattern results from the chaotic bone remodelling process characteristic of this condition.</span></li></ul>",
      "correct_choice_id": 222026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10126,
      "choices": [
        {
          "id": 40470,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypochloremic, hypokalemic acidosis</span></p>"
        },
        {
          "id": 40471,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypochloremic, hypokalemic alkalosis</span></p>"
        },
        {
          "id": 40472,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemic hyperchloremic alkalosis</span></p>"
        },
        {
          "id": 40473,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperchloremic hypokalemic acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child with infantile hypertrophic pyloric stenosis has multiple episodes of non-bilious vomiting. Which of the following metabolic abnormalities is likely to be seen in this condition? (NEET PG 2021)</span></p>",
      "unique_key": "Q7819251",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509781,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hypochloremic, hypokalemic alkalosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infantile hypertrophic pyloric stenosis (IHPS) is a condition where there is constriction and obstruction of the gastric outlet due to hypertrophy of the circular muscle of the pylorus. This results in persistent vomiting, which leads to the loss of hydrogen and chloride ions in the gastric acid and potassium ions in the gastric mucus. As a consequence, the multiple episodes of non-bilious vomiting in IHPS can cause hypochloremia and hypokalemia, leading to alkalosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cause of metabolic alkalosis: The hydrogen ions that normally reach the duodenum are now lost due to vomiting. Hence, the bicarbonate secretion from the pancreas is decreased, thereby increasing the bicarbonate levels in the serum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Causes of hypokalemia:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Because of alkalosis, the hydrogen ions exit from the cells in exchange for potassium leading to hypokalemia.</span></li><li><span style=\"font-size:12.0pt;\">Loss of fluid due to excessive vomiting activates the RAAS pathway. This worsens hypokalemia as the aldosterone causes active reabsorption of sodium in exchange for the secretion of K* and H* ions into the urine. The loss of H* ions in urine lowers the urinary pH, resulting in paradoxical aciduria</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/28/picture151.jpg\" alt=\"\" width=\"1000\" height=\"558\"></p><p>&nbsp;</p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture1_Eg7RZcO.jpg\" alt=\"\" width=\"400\" height=\"343\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infantile hypertrophic pyloric stenosis leads to hypochloremic, hypokalemic metabolic alkalosis due to persistent vomiting and loss of gastric acid.</span></p>",
      "correct_choice_id": 40471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57885,
      "choices": [
        {
          "id": 230901,
          "text": "<p><span style=\"font-size:12.0pt;\">VII &amp; X</span></p>"
        },
        {
          "id": 230902,
          "text": "<p><span style=\"font-size:12.0pt;\">IX &amp; X</span></p>"
        },
        {
          "id": 230903,
          "text": "<p><span style=\"font-size:12.0pt;\">V &amp; IX</span></p>"
        },
        {
          "id": 230904,
          "text": "<p><span style=\"font-size:12.0pt;\">VII &amp; IX</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Injury to which nerve results in absent gag reflex? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-110046.jpg\" alt=\"\" width=\"400\" height=\"233\"></span></p>",
      "unique_key": "Q8004017",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510011,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) IX &amp; X</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The gag reflex, also known as the pharyngeal reflex, is a protective mechanism that prevents foreign objects from entering the throat. This reflex involves both sensory and motor components:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Sensory Component (Afferent):</strong> The sensory part of the gag reflex is mediated by the Glossopharyngeal nerve (Cranial Nerve IX). When the posterior wall of the pharynx or the palate is touched, the sensory information is carried by the Glossopharyngeal nerve to the medulla oblongata.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Motor Component (Efferent):</strong> The motor response, which causes the contraction of the pharyngeal muscles, is mediated by the Vagus nerve (Cranial Nerve X). This nerve provides the efferent pathway, leading to the muscle contraction observed in the gag reflex.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Injury to either of these nerves can disrupt the reflex: damage to CN IX affects the sensory input, while damage to CN X affects the motor response, resulting in an absent gag reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-110131.jpg\" alt=\"\" width=\"700\" height=\"500\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A (VII &amp; X):</strong> Cranial Nerve VII (Facial nerve) is not involved in the gag reflex. The Facial nerve primarily controls muscles of facial expression and does not play a role in the sensory or motor aspects of the gag reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C (V &amp; IX):</strong> Cranial Nerve V (Trigeminal nerve) is responsible for sensation in the face and motor functions such as biting and chewing, not for the gag reflex. Therefore, its involvement in the gag reflex is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D (VII &amp; IX):</strong> While Cranial Nerve IX is correctly identified as part of the reflex, Cranial Nerve VII is not involved. This makes the pairing incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The gag reflex involves the Glossopharyngeal nerve (CN IX) for sensory input and the Vagus nerve (CN X) for motor response. Damage to either nerve can result in an absent gag reflex.</span></p>",
      "correct_choice_id": 230902,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57885/Neet_Pg_Aug_2024_Anatomy_Q_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/57885/Neet_Pg_Aug_2024_Anatomy_Q_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10189,
      "choices": [
        {
          "id": 40722,
          "text": "<p><span style=\"font-size:18px;\">Hepatitis A</span></p>"
        },
        {
          "id": 40723,
          "text": "<p><span style=\"font-size:18px;\">Hepatitis B</span></p>"
        },
        {
          "id": 40724,
          "text": "<p><span style=\"font-size:18px;\">Rabies</span></p>"
        },
        {
          "id": 40725,
          "text": "<p><span style=\"font-size:18px;\">Varicella</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which vaccine among the options is not recommended for use during pregnancy? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
      "unique_key": "Q6042780",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509777,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Varicella</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Varicella vaccine is contraindicated in pregnant women because it is a live attenuated vaccine. Live vaccines contain weakened forms of the virus, which can potentially cross the placenta and infect the fetus, leading to congenital infection or other complications. The primary concern is that the live virus, although weakened, may still pose a risk to the developing fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Live vaccines are generally avoided during pregnancy to minimize any potential risks to the fetus. Pregnant women are advised to receive inactivated vaccines, which do not contain live pathogens and are considered safer for both the mother and the unborn child.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Hepatitis A:</strong> &nbsp;The Hepatitis A vaccine is an inactivated (killed) vaccine. It is generally considered safe during pregnancy and can be administered if the benefits outweigh the risks, especially if the woman is at high risk for Hepatitis A infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Hepatitis B:&nbsp;</strong> The Hepatitis B vaccine is a recombinant vaccine, which does not contain live virus. It is safe to use during pregnancy and is recommended for pregnant women who are at risk of Hepatitis B infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Rabies:&nbsp;</strong> The Rabies vaccine is an inactivated vaccine. It is considered safe during pregnancy and should be administered if there is a risk of rabies exposure, as the disease itself is fatal if not treated promptly.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125429.jpg\" alt=\"\" width=\"794\" height=\"652\"></span></p>",
      "correct_choice_id": 40725,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5598,
      "choices": [
        {
          "id": 22364,
          "text": "<p><span style=\"font-size:12.0pt;\">18-22 years</span></p>"
        },
        {
          "id": 22365,
          "text": "<p><span style=\"font-size:12.0pt;\">22-25 years</span></p>"
        },
        {
          "id": 22366,
          "text": "<p><span style=\"font-size:12.0pt;\">16-18 years</span></p>"
        },
        {
          "id": 22367,
          "text": "<p><span style=\"font-size:12.0pt;\">12-14 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Basiocciput fuses with basisphenoid at what age?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q4940363",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510009,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 18-22 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The fusion of the basiocciput with the basisphenoid occurs at around 18-22 years of age. This process is part of the normal skeletal development during late adolescence and early adulthood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fusion Age:&nbsp;</strong>The fusion of these bones is a significant event in the maturation of the cranial base, occurring between the ages of 18 and 22 years. This fusion helps in the formation of a solid and stable base for the skull.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fusion of Basiocciput with basisphenoid is seen around 18-22 years.</span></p>",
      "correct_choice_id": 22364,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10044,
      "choices": [
        {
          "id": 40142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">C1 inhibitor</span></span></span></p>"
        },
        {
          "id": 40143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decay accelerating factor</span></span></span></p>"
        },
        {
          "id": 40144,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CD59</span></span></span></p>"
        },
        {
          "id": 40145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">C5 convertase</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following protein deficiency is responsible for Hereditary Angioedema? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q7940218",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509773,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) C1 inhibitor </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe swelling (angioedema). The condition is caused by a deficiency or dysfunction of the <strong>C1 inhibitor</strong> protein. C1 inhibitor is crucial in regulating the complement system, particularly the classical pathway, by inhibiting the activity of C1 esterase. In the absence or dysfunction of C1 inhibitor, uncontrolled activation of the complement pathway occurs, leading to excessive production of bradykinin, a potent vasodilator that causes the symptoms of angioedema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Decay accelerating factor</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Also known as CD55, this protein is responsible for regulating the complement system on cell surfaces, preventing damage to host cells. Deficiency of CD55 is associated with <strong>Paroxysmal Nocturnal Hemoglobinuria (PNH)</strong>, not hereditary angioedema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. CD59</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This protein is also involved in the regulation of the complement system by inhibiting the formation of the membrane attack complex (MAC). Like CD55, CD59 deficiency is associated with <strong>Paroxysmal Nocturnal Hemoglobinuria (PNH)</strong>, not hereditary angioedema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. C5 convertase</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is an enzyme complex that plays a role in the complement cascade by cleaving C5 into C5a and C5b, leading to the formation of the membrane attack complex. Deficiencies in components of C5 convertase can lead to increased susceptibility to infections, particularly with Neisseria species, but it is not associated with hereditary angioedema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-150719.jpg\" style=\"height:451px; width:1000px\" /></p>",
      "correct_choice_id": 40142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12008,
      "choices": [
        {
          "id": 47996,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brown-Sequard syndrome</span></span></span></p>"
        },
        {
          "id": 47997,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tabes dorsalis</span></span></span></p>"
        },
        {
          "id": 47998,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringobulbia</span></span></span></p>"
        },
        {
          "id": 47999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A female presented with loss of pain and temperature, but her touch sensation was intact. Imaging showed cavitation around the central canal. What is the probable diagnosis? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q5407363",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509772,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><span style=\"font-size:12.0pt\">&nbsp;<strong>D) Syringomyelia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia is characterized by the presence of a fluid-filled cavity or syrinx within the spinal cord, which typically expands over time. This condition most commonly affects the cervical and thoracic regions of the spinal cord. The classic presentation includes a loss of pain and temperature sensation in a &quot;cape-like&quot; distribution over the shoulders and back, while touch, vibration, and proprioception (posterior column sensations) remain intact. This pattern of sensory loss is due to the disruption of the decussating (crossing) fibers of the spinothalamic tract, which carry pain and temperature sensations. The cavitation around the central canal of the spinal cord is a hallmark of syringomyelia and leads to the aforementioned symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Brown-Sequard syndrome: </span></strong><span style=\"font-size:12.0pt\">This condition results from hemisection or damage to one half of the spinal cord. It typically presents with ipsilateral motor loss and loss of proprioception and vibration sense, and contralateral loss of pain and temperature sensation below the level of the lesion. This does not match the described symptoms and imaging findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tabes dorsalis: </span></strong><span style=\"font-size:12.0pt\">This is a late manifestation of neurosyphilis, characterized by degeneration of the dorsal columns of the spinal cord, leading to impaired proprioception and vibration sense, ataxia, and lightning pains. It does not cause cavitation around the central canal or the specific dissociated sensory loss seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Syringobulbia: </span></strong><span style=\"font-size:12.0pt\">This is a similar condition to syringomyelia but involves the brainstem (medulla oblongata) rather than the spinal cord. It presents with symptoms related to cranial nerve involvement such as dysphagia, dysarthria, and facial pain. The patient&#39;s symptoms and imaging findings are more consistent with syringomyelia, not syringobulbia</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia presents with a loss of pain and temperature sensation while preserving touch sensation, and is characterized by cavitation around the central canal of the spinal cord.</span></span></span></p>",
      "correct_choice_id": 47999,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20249,
      "choices": [
        {
          "id": 80957,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid receptor antibody</span></p>"
        },
        {
          "id": 80958,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive Iodine Uptake</span></p>"
        },
        {
          "id": 80959,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasensitive thyrotropin</span></p>"
        },
        {
          "id": 80960,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-thyroid peroxidase antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old medical student with a 2-month history of palpitations, sweating, and restlessness. He also complains of a sweaty palm. His appearance is as shown in the picture. What is the next step in evaluation? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/30/screenshot-2024-07-30-143515.jpg\" alt=\"\" width=\"300\" height=\"154\"></span></p>",
      "unique_key": "Q8785282",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509766,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ultrasensitive thyrotropin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms and the clinical image strongly suggest Graves' Orbitopathy (also known as Graves' Ophthalmopathy), characterized by proptosis, eyelid edema, and eye congestion. The most common cause of both unilateral and bilateral exophthalmos is Graves' disease, an autoimmune disorder leading to hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The next step in evaluating a patient suspected of having hyperthyroidism is to perform a thyroid function test (TFT), with the most important initial test being the measurement of Thyroid Stimulating Hormone (TSH). The ultrasensitive thyrotropin test, which measures TSH levels, is crucial because it helps in determining the presence of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Graves' disease, TSH levels are typically very low or undetectable, while <strong>free T4</strong> and Total T3 levels are elevated (primary hyperthyroidism).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IOC – MRI of the orbit</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TOC – mild – moderate disease – conservative management</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mod.-severe disease – first line TOC – CS (Dexamethasone); </span><span style=\"background-color:white;color:#202124;font-size:12.0pt;\">Teprotumumab (IGF1 receptor inhibitor Mab)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thyroid receptor antibody:</strong> This test is specific <strong>for confirming</strong> Graves' disease, but it is not the first step. It is used after initial thyroid function tests suggest hyperthyroidism to confirm the diagnosis. The antibodies known as TRAb (TSH receptor antibody/ Thyroid receptor Ab).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2 forms of TRAb – TSI (Thyroid Stimulating Immunoglobulin) and</span></p><p style=\"margin-left:48px;\"><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp; TBII (Thyroid binding Inhibitory Immunoglobulin)</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Radioactive Iodine Uptake:</strong> This test helps to differentiate between various causes of hyperthyroidism, such as Graves' disease and toxic multinodular goiter. It is not the first step but follows initial thyroid function tests if hyperthyroidism is confirmed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anti thyroid peroxidase antibody:</strong> This antibody is not specific for Graves' disease. It is more commonly associated with Hashimoto's thyroiditis and other autoimmune thyroid disorders, making it less relevant for initial evaluation in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first and most crucial test in the evaluation of suspected hyperthyroidism, such as in a case suggestive of Graves' disease, is the measurement of ultrasensitive thyrotropin (TSH) levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Confirmatory Diagnosis – by TRAbs (Thyroid receptor antibodies)</span></p>",
      "correct_choice_id": 80959,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55494,
      "choices": [
        {
          "id": 221433,
          "text": "<p><span style=\"font-size:12.0pt;\">1 per 30,000</span></p>"
        },
        {
          "id": 221434,
          "text": "<p><span style=\"font-size:12.0pt;\">1 per 50,000</span></p>"
        },
        {
          "id": 221435,
          "text": "<p><span style=\"font-size:12.0pt;\">1 per 100,000</span></p>"
        },
        {
          "id": 221436,
          "text": "<p><span style=\"font-size:12.0pt;\">1 per 150,000</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The defined population norm for Urban-Primary health centre in our country is one such centre per: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5977695",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510012,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) 1 per 50,000</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In India, the population norm for establishing a UPHC is one center per 50,000 population. These centers are intended to provide primary healthcare services in urban areas, addressing the healthcare needs of urban populations efficiently.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The UPHCs are equipped to deliver a range of health services, including preventive, promotive, curative, and rehabilitative care.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In UPHC, one Urban Auxiliary Nurse Midwife (ANM) per 10,000 population, and one Urban Social Health Activist (USHA) per 1,000 to 2,500 population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Remember –</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Population norm for rural PHC</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">1 per 30,000 populations in plain area</span></li><li><span style=\"font-size:12.0pt;\">1 per 20,000 populations in tribal and hilly areas</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The population norm for establishing an Urban Primary Health Centre (UPHC) in India is one center per 50,000 populations.</span></p>",
      "correct_choice_id": 221434,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21893,
      "choices": [
        {
          "id": 87540,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Median nerve </span></span></span></p>"
        },
        {
          "id": 87541,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Musculocutaneous nerve</span></span></span></p>"
        },
        {
          "id": 87542,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Axillary nerve</span></span></span></p>"
        },
        {
          "id": 87543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radial nerve</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient presenting with multiple humeral shaft fracture, following which he had difficulty in flexion of elbow and supination of forearm. He also complaints of loss of sensation over lateral side of forearm. Which nerve is damaged?&nbsp;&nbsp;(NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q8507261",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509760,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Musculocutaneous nerve</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MUSCULOCUTANEOUS NERVE (C5, 6, 7)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is one of the two terminal branches of the lateral cord, the other being the lateral root of the median nerve.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It supplies coracobrachialis, both heads of biceps brachii and most of branchialis, and continues as the lateral cutaneous nerve of forearm, running down the lateral aspect of the forearm.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Injury to the musculocutaneous nerve results in weakness of supination (biceps) and flexion (biceps, brachialis, and coracobrachialis) of the forearm and loss of sensation on the lateral side of the forearm.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is damaged in shoulder dislocation, second common to axillary nerve.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Median nerve.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Median nerve injury is associated with a fracture of the humerus, especially supracondylar fractures. Entrapment at the elbow between the two heads of pronator teres (pronator teres syndrome) and under the flexor retinaculum (carpal tunnel syndrome)<strong> </strong>are also the causes.<strong> </strong>Median nerve injury at elbow level causes paralysis of forearm pronators. This keeps the forearm in supine position. When long flexors (except FCU and medial &frac12; of FDP) are paralyzed, the wrist flexion becomes weak and is accompanied by adduction due to paralysis of FCR and intact FCU. Flexion of terminal phalanx of thumb is lost because of paralysis of FPL. Flexion of interphalangeal joints of index and middle fingers is lost, so there is a <strong>pointing index</strong> or <strong>positive Ochsner clasp</strong> or <strong>Benediction test</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Axillary nerve.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Injured in fracture of surgical neck of humerus, shoulder dislocation (anterior and inferior) and intramuscular injections. There is deltoid muscle palsy, loss of rounded contour of shoulder &ndash; giving shoulder a flattened&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">appearance and produce hollow inferior to acromion, weakness of abduction (15-90&deg;), Teres minor palsy, and sensory loss over lower half of deltoid (regimental badge area).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Radial nerve.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is usually injured in fractures of shaft humerus, injection palsy, Saturday night palsy and Crutch palsy. In radial nerve injury, there is sensory loss in the area supplied by the posterior cutaneous nerve of forearm. Wrist, thumb and finger extension is lost i.e., wrist, thumb and fingers drop. Loss of extension of wrist is wrist drop; of thumb is thumb drop; of MCP joint of finger is finger drop.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Difficulty in flexion of elbow and supination of forearm, with loss of sensation over lateral side of forearm are the symptoms associated with musculocutaneous nerve injury. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 87541,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5662,
      "choices": [
        {
          "id": 22620,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">12-14</span></span></span></span></p>"
        },
        {
          "id": 22621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6-8</span></span></span></span></p>"
        },
        {
          "id": 22622,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">7-9</span></span></span></span></p>"
        },
        {
          "id": 22623,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10-11</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the ideal number of antenatal visits?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q5666419",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509769,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 12-14 </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ideal number of antenatal visits as recommended by various guidelines:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MOHFW (Indian guidelines)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At least 4 visits including the first (registration visit) &ndash; minimum requirement.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suggested schedule:</span></span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st Visit: Within 12 weeks</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2nd Visit: 14-26 weeks</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3rd Visit: 28-34 weeks</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4th Visit: 36 weeks to term</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WHO (2016)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recommends 8 visits:</span></span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1st Trimester:</span></span></span></span>\r\n\t\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact 1: Up to 12 weeks</span></span></span></span></li>\r\n\t\t\t</ul>\r\n\t\t\t</li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2nd Trimester:</span></span></span></span>\r\n\t\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact 2: 20 weeks</span></span></span></span></li>\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact 3: 26 weeks</span></span></span></span></li>\r\n\t\t\t</ul>\r\n\t\t\t</li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3rd Trimester:</span></span></span></span>\r\n\t\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact 4: 30 weeks</span></span></span></span></li>\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact 5: 34 weeks</span></span></span></span></li>\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact 6: 36 weeks</span></span></span></span></li>\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact 7: 38 weeks</span></span></span></span></li>\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contact 8: 40 weeks</span></span></span></span></li>\r\n\t\t\t</ul>\r\n\t\t\t</li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACOG (American College of Obstetricians and Gynecologists)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ideally recommends:</span></span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Once every month till 28 weeks</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Every 2 weeks till 36 weeks</span></span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weekly till 40 weeks</span></span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This totals approximately 12-14 visits.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ideal number of antenatal visits is 12-14, as recommended by ACOG, ensuring comprehensive prenatal care.</span></span></span></span></p>",
      "correct_choice_id": 22620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11830,
      "choices": [
        {
          "id": 47286,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 only</span></span></p>"
        },
        {
          "id": 47287,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 and 3</span></span></p>"
        },
        {
          "id": 47288,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3 and 4</span></span></p>"
        },
        {
          "id": 47289,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3 and 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 60-year-old male patient with critical mitral stenosis presented with atrial fibrillation. He has a history of multiple episodes of transient ischemic attacks. Which of the following are true regarding the prevention of stroke in this patient? (INICET NOV 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Only aspirin is given</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin is given</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct oral anticoagulants are not indicated</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mitral valvotomy should be recommended</span></span></span></li>\r\n</ol>",
      "unique_key": "Q6646539",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509759,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 2 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with critical mitral stenosis and atrial fibrillation, particularly one with a history of transient ischemic attacks (TIA), anticoagulation therapy is essential. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2. Warfarin is the preferred anticoagulant in cases of severe mitral stenosis due to its proven effectiveness in preventing thromboembolic events. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3. Direct oral anticoagulants (DOACs) are not recommended in this scenario as they are not indicated for patients with moderate to severe mitral stenosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1. Aspirin alone is insufficient to prevent stroke in this context. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4. Mitral valvotomy is not recommended at this point because performing the procedure could dislodge existing clots, leading to embolic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with critical mitral stenosis and atrial fibrillation, especially those with a history of TIA, Warfarin should be given for stroke prevention, and direct oral anticoagulants are not indicated.</span></span></span></p>",
      "correct_choice_id": 47287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5605,
      "choices": [
        {
          "id": 22392,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral fidaxomicin is used for treatment</span></p>"
        },
        {
          "id": 22393,
          "text": "<p><span style=\"font-size:12.0pt;\">It is toxin mediated</span></p>"
        },
        {
          "id": 22394,
          "text": "<p><span style=\"font-size:12.0pt;\">IgM assay is used to confirm the diagnosis</span></p>"
        },
        {
          "id": 22395,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudomembrane consists of leukocytes, fibrin, and cellular debris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman with recurrent diarrhea is prescribed a broad-spectrum antibiotic. Which of the following is not true regarding Clostridium difficile infection?</span><span style=\"font-size:10.5pt;\"> &nbsp;(NEET PG 2022)</span></p>",
      "unique_key": "Q6940250",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509765,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) IgM assay is used to confirm the diagnosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">IgM assay cannot be used to confirm a diagnosis of Clostridium difficile infection. The diagnosis is based on a combination of clinical criteria and detection of toxin in stool samples.</span></li><li><span style=\"font-size:12.0pt;\">C. difficile, a gram-positive anaerobic bacillus, causes Clostridioides (formerly Clostridium) difficile infection (CDI) after ingestion of spores of the organism.</span></li><li><span style=\"font-size:12.0pt;\">The more severe form of the condition is known as pseudomembranous colitis (PMC). It is most commonly associated with prolonged antimicrobial use which interferes with the commensal colonic microflora. The most commonly implicated antibiotics are cephalosporins, ampicillin, and clindamycin.</span></li><li><span style=\"font-size:12.0pt;\">The spores are spread by contact with the feces of affected individuals or asymptomatic carriers.</span></li><li><span style=\"font-size:12.0pt;\">The spores germinate in the small intestine and produce two toxins - toxin A (enterotoxin) and toxin B (cytotoxin). These interfere with the epithelial-cell barrier function and result in diarrhea and pseudomembrane formation.</span></li><li><span style=\"font-size:12.0pt;\">The pseudomembranes appear as small whitish-yellow plaques initially which later coalesce to involve the entire colon wall. It contains necrotic leukocytes, fibrin, and cellular debris. The anamnestic IgG response determines which patients develop the disease or remain asymptomatic.</span></li><li><span style=\"font-size:12.0pt;\">Symptoms include diarrhea, fever, and abdominal pain. The diagnosis is based on a combination of clinical criteria and detection of toxin &nbsp;A Or Toxin B or the organism in stool samples. The mere presence of bacteria in stool does not itend that the patient has the disease as clostridoides difficile is a commensal in the gut. Onlly confirmed toxin detection suggests significant infection with clostridoides difficile &nbsp;This can be done by nucleic acid amplification testing (NAAT methods such as polymerase chain reaction (PCR) or by culture.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Discontinuation of any ongoing antimicrobials and hydration are general measures that are recommended. Oral fidaxomicin or vancomycin is the first-line treatment. Oral metronidazole can be used when these are not available.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Oral fidaxomicin is used for treatment:</strong> This is true; fidaxomicin is a first-line treatment for C. difficile infection, especially in cases of recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is toxin mediated:</strong> True; the clinical manifestations of CDI are due to the effects of toxins A and B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pseudomembrane consists of leukocytes, fibrin, and cellular debris:</strong> Also true, this describes the characteristic appearance of the pseudomembrane seen in pseudomembranous colitis, a severe form of CDI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clostridium difficile infection is diagnosed primarily through the detection of toxins rather than IgM assays is crucial for appropriate management. This recognition guides the effective use of specific treatments such as oral fidaxomicin or vancomycin, aimed at countering the effects of these toxins and managing the symptoms of the infection.</span></p>",
      "correct_choice_id": 22394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56134,
      "choices": [
        {
          "id": 223961,
          "text": "<p><span style=\"font-size:12.0pt;\">Tangier's disease</span></p>"
        },
        {
          "id": 223962,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial hyperchylomicronemia</span></p>"
        },
        {
          "id": 223963,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial hypercholesterolemia</span></p>"
        },
        {
          "id": 223964,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial Dysbetalipoproteinemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with xanthomas on the Achilles tendon. Which of the following is the diagnosis? (NEET PG 2024)</span></p>",
      "unique_key": "Q3454228",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509774,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Familial hypercholesterolemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Familial hypercholesterolemia is a genetic disorder characterized by high levels of low-density lipoprotein (LDL) cholesterol in the blood. A hallmark of this condition is the presence of tendon xanthomas, which are cholesterol deposits typically found in tendons, most commonly in the Achilles tendon. This condition is caused by mutations affecting the LDL receptor or apolipoprotein B, which impair the clearance of LDL from the bloodstream. The Achilles tendon xanthomas are a distinctive feature that helps differentiate familial hypercholesterolemia from other lipid disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Tangier's disease</strong>: Tangier's disease is characterized by very low levels of high-density lipoprotein (HDL) cholesterol and the presence of orange-colored tonsils due to the accumulation of cholesterol esters. It does not cause tendon xanthomas, especially on the Achilles tendon, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Familial hyperchylomicronemia</strong>: This condition involves elevated triglycerides due to the accumulation of chylomicrons, often leading to eruptive xanthomas rather than tendon xanthomas. It is primarily associated with defects in lipoprotein lipase or apolipoprotein C-II and is not associated with the specific finding of Achilles tendon xanthomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Familial Dysbetalipoproteinemia</strong>: This condition, associated with a defect in apolipoprotein E, leads to increased levels of both cholesterol and triglycerides, often resulting in palmar xanthomas or tuberous xanthomas, not the specific Achilles tendon xanthomas seen in familial hypercholesterolemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Familial hypercholesterolemia is associated with high LDL cholesterol levels and the presence of tendon xanthomas, particularly on the Achilles tendon</span></p>",
      "correct_choice_id": 223963,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57619,
      "choices": [
        {
          "id": 229845,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is mostly in children</span></span></span></p>"
        },
        {
          "id": 229846,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is usually malignant</span></span></span></p>"
        },
        {
          "id": 229847,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is mostly bilateral</span></span></span></p>"
        },
        {
          "id": 229848,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It can be associated with MEN 2A</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is the correct statement about a patient with a retroperitoneal mass, episodic hypertension, palpitations, and increased urinary VMA levels? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q9131005",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509768,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) It can be associated with MEN 2A</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical scenario described is <strong>characteristic of pheochromocytoma</strong>, a catecholamine-secreting tumor that typically presents with episodic hypertension, palpitations, headaches, and elevated urinary vanillylmandelic acid (VMA) levels. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pheochromocytomas are known to be associated with multiple endocrine neoplasia type 2A (MEN 2A), which involves <strong>mutations in the RET gene</strong>. Patients with MEN 2A often present with pheochromocytoma, medullary thyroid cancer, and parathyroid hyperplasia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Remember</span></strong><span style=\"font-size:12.0pt\"> &ndash; The genes associated with <strong>pheochromocytoma</strong>, includes the <strong>RET gene</strong>, <strong>P53 gene</strong>, <strong>VHL gene</strong>, and the <strong>succinate dehydrogenase B (SDHB)</strong> gene.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is mostly in children</span></strong><span style=\"font-size:12.0pt\">: Pheochromocytomas are more common in adults, and only about <strong>10%</strong> of cases occur in children. Therefore, this statement is incorrect as the majority of cases are found in adults.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. It is usually malignant</span></strong><span style=\"font-size:12.0pt\">: Pheochromocytomas are benign in about 90% of cases. Malignancy is seen in only <strong>about 10%</strong> of cases, so this statement is incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. It is mostly bilateral</span></strong><span style=\"font-size:12.0pt\">: Pheochromocytomas are predominantly unilateral. Bilateral tumors are seen in <strong>only 10% of cases</strong>, often in familial syndromes such as MEN 2A. Hence, this statement is not accurate for the majority of cases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pheochromocytomas are catecholamine-secreting tumors associated with episodic hypertension and increased urinary VMA levels. They are commonly linked with MEN 2A syndrome, which involves RET gene mutations.</span></span></p>",
      "correct_choice_id": 229848,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57582,
      "choices": [
        {
          "id": 229697,
          "text": "<p><span style=\"font-size:18px;\">09</span></p>"
        },
        {
          "id": 229698,
          "text": "<p><span style=\"font-size:18px;\">18</span></p>"
        },
        {
          "id": 229699,
          "text": "<p><span style=\"font-size:18px;\">50</span></p>"
        },
        {
          "id": 229700,
          "text": "<p><span style=\"font-size:18px;\">100</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>In a community, there were 550 births in a year out of which 50 were stillbirths. There were 09 deaths among newborns during 0-7 days of life. An additional 41 deaths occurred during 8-28 days of life. Calculate the Early Neonatal Mortality rate for the given community. </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
      "unique_key": "Q8854112",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509771,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 18</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Early Neonatal Mortality Rate (ENMR) measures the number of deaths of newborns within the first 7 days of life per 1,000 live births. It focuses specifically on early neonatal deaths, which occur during the first week of life.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Calculation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Total births:</strong> 550</span></li><li><span style=\"font-size:18px;\"><strong>Stillbirths:</strong> 50</span></li><li><span style=\"font-size:18px;\"><strong>Live births (LB):</strong> 550 - 50 = 500</span></li><li><span style=\"font-size:18px;\"><strong>Early Neonatal Deaths (ENND):</strong> 9 deaths during 0-7 days.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>ENMR formula:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173647.jpg\" alt=\"\" width=\"700\" height=\"126\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Therefore, the Early Neonatal Mortality Rate is 18 deaths per 1,000 live births.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Early Neonatal Mortality Rate is calculated as the number of early neonatal deaths (0-7 days) per 1,000 live births.</span></p>",
      "correct_choice_id": 229698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14874,
      "choices": [
        {
          "id": 59456,
          "text": "<p><span style=\"font-size:12.0pt;\">Spinous process</span></p>"
        },
        {
          "id": 59457,
          "text": "<p><span style=\"font-size:12.0pt;\">Pedicle</span></p>"
        },
        {
          "id": 59458,
          "text": "<p><span style=\"font-size:12.0pt;\">Lamina</span></p>"
        },
        {
          "id": 59459,
          "text": "<p><span style=\"font-size:12.0pt;\">Facet joint</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In spine straightening surgeries, screws used for fixation are inserted through which of the following parts of the vertebra? (INICET NOV 2020)</span></p>",
      "unique_key": "Q7444674",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509757,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p style=\"margin-left:0cm;text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. B)</strong> <strong>Pedicle</strong></span></p><p style=\"margin-left:0cm;text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Spinal&nbsp;instrumentation&nbsp;(rods, &nbsp;screws, hooks, etc.) are applied to the region of the spine to be corrected through transpedicular route and bone graft&nbsp;is added.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">In the spine straightening surgery, to stabilize the spine, screws are placed on the pedicles of the vertebral bone.&nbsp;</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-04-12%20122712.jpg\" width=\"704\" height=\"397\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Hooks may also be used in conjunction with screws, and are placed around the pedicle or around the lamina.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Rods are then secured in the screw heads, connecting adjacent vertebrae.&nbsp;</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">The rods are shaped to match the desired corrected curvature of the spine, and are attached to the screws and/or hooks.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Bone graft material is placed around the final assembly and as the spine heals, spinal fusion is accomplished by bone growth between the vertebrae. This bone growth permanently fixes the spine in the desired position. The implants hold the spine in the corrected position while the spine fuses.</span></p></li></ul><p style=\"margin-left:0cm;text-align:justify;\">&nbsp;</p><p style=\"margin-left:0cm;text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;text-align:justify;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Pedicle of the vertebra is the area used to fixate the screws through during the spine straightening surgeries for scoliosis.&nbsp;</span></p></li></ul>",
      "correct_choice_id": 59457,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10496,
      "choices": [
        {
          "id": 41950,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic myeloid leukemia</span></p>"
        },
        {
          "id": 41951,
          "text": "<p><span style=\"font-size:12.0pt;\">Aplastic anemia</span></p>"
        },
        {
          "id": 41952,
          "text": "<p><span style=\"font-size:12.0pt;\">Hairy cell leukemia</span></p>"
        },
        {
          "id": 41953,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are associated with massive splenomegaly except: (AIIMS NOV 2021)</span></p>",
      "unique_key": "Q2132145",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510006,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Aplastic anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All the above are associated with massive splenomegaly except aplastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Aplastic anemia</strong> is characterized by pancytopenia (a reduction in red blood cells, white blood cells, and platelets) due to the failure of the bone marrow. A key feature of aplastic anemia is the absence of splenomegaly. In fact, the presence of splenomegaly in a patient with pancytopenia often argues against the diagnosis of aplastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">There are several potential <strong>causes of splenomegaly:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Liver disease (cirrhosis, hepatitis): Parenchymal liver disease causes increased vascular pressure leading to an increase in spleen size.</span></li><li><span style=\"font-size:12.0pt;\">Hematologic malignancies (lymphomas, leukemias, myeloproliferative disorders): Neoplastic cells cause infiltration of the spleen leading to splenomegaly.</span></li><li><span style=\"font-size:12.0pt;\">Venous thrombosis (portal or hepatic vein thrombosis): This leads to an increase in vascular pressure leading to splenomegaly.</span></li><li><span style=\"font-size:12.0pt;\">Splenic congestion (venous thrombosis, portal hypertension, congestive heart failure).</span></li><li><span style=\"font-size:12.0pt;\">Cytopenias (Immune thrombocytopenic purpura, autoimmune hemolytic anemia, immune-mediated neutropenia, Felty syndrome): Immune-mediated destruction of red blood cells, white blood cells or platelets lead to functional splenomegaly</span></li><li><span style=\"font-size:12.0pt;\">Splenic sequestration (pediatric sickle cell disease, hemolytic anemias, thalassemias).</span></li><li><span style=\"font-size:12.0pt;\">Acute or chronic infection (bacterial endocarditis, infectious mononucleosis, HIV, malaria, tuberculosis, histiocytosis, abscess).</span></li><li><span style=\"font-size:12.0pt;\">Connective tissue diseases (systemic lupus erythematosus, rheumatoid arthritis, Adult-onset Still's disease, and some familial autoinflammatory syndromes).[4][5]</span></li><li><span style=\"font-size:12.0pt;\">Infiltrative disorders (sarcoidosis, amyloidosis, glycogen storage diseases).</span></li><li><span style=\"font-size:12.0pt;\">Splenic sequestration (pediatric sickle cell, hemolytic anemias, thalassemias).</span></li><li><span style=\"font-size:12.0pt;\">Focal lesions (hemangiomas, abscess, cysts, metastasis).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aplastic anemia is a syndrome of chronic primary hematopoietic failure. This results in pancytopenia (anemia, neutropenia, and thrombocytopenia). <strong>Splenomegaly is characteristically absent; if it is present, the diagnosis of aplastic anemia should be seriously questioned. Similarly, splenomegaly is also never seen in cases of ITP.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg. 1239, 1173</strong></span></p>",
      "correct_choice_id": 41951,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54847,
      "choices": [
        {
          "id": 218849,
          "text": "<p><span style=\"font-size:12.0pt;\">Red</span></p>"
        },
        {
          "id": 218850,
          "text": "<p><span style=\"font-size:12.0pt;\">Green</span></p>"
        },
        {
          "id": 218851,
          "text": "<p><span style=\"font-size:12.0pt;\">Yellow</span></p>"
        },
        {
          "id": 218852,
          "text": "<p><span style=\"font-size:12.0pt;\">Black</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In triage, immediately life-threatening injury is categorized as what color code? (INICET MAY 2024)</span></p>",
      "unique_key": "Q4888202",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509779,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Red</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the triage system, which is used to prioritize patients based on the severity of their condition, an immediately life-threatening injury is classified under the <strong>Red</strong> color code. This indicates that the patient requires immediate medical attention to prevent death or severe complications. The Red category is the highest priority in triage, where intervention is needed within 0 to 6 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Green</strong>: This color code is used for ambulatory patients with non-life-threatening injuries. These patients are stable and can wait for treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Yellow</strong>: The Yellow category is for urgent cases where intervention is required within 6 to 24 hours. While these patients need prompt attention, their condition is not as immediately critical as those in the Red category.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Black</strong>: The Black category is reserved for patients who are either deceased or moribund (those who are unlikely to survive). This represents the lowest priority in triage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a triage situation, an <strong>immediately life-threatening injury is classified under the Red color code</strong>, indicating the need for urgent medical intervention.</span></p>",
      "correct_choice_id": 218849,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57135,
      "choices": [
        {
          "id": 227929,
          "text": "<p><span style=\"font-size:12.0pt;\">Penectomy with inguinal dissection</span></p>"
        },
        {
          "id": 227930,
          "text": "<p><span style=\"font-size:12.0pt;\">Orchidectomy</span></p>"
        },
        {
          "id": 227931,
          "text": "<p><span style=\"font-size:12.0pt;\">Debridement</span></p>"
        },
        {
          "id": 227932,
          "text": "<p><span style=\"font-size:12.0pt;\">Penectomy with orchidectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the surgical procedure: (NEET PG 2024)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image%20(2).png\" width=\"548\" height=\"431\"></p>",
      "unique_key": "Q4011218",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509764,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;A) Penectomy with inguinal dissection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is Penectomy with inguinal dissection. The provided images show a post-operative scenario where the penis has been surgically removed, and a perineal urethrostomy has been created with a catheter in place. Additionally, drains are visible in the upper groin area, which are indicative of bilateral inguinal lymph node dissection. This combination of procedures is typical in the management of penile cancer, where both the primary tumor and regional lymph nodes are addressed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. &nbsp;Orchidectomy:</strong> Orchidectomy, or surgical removal of one or both testicles, is not typically part of the treatment for penile cancer unless testicular involvement is specifically noted, which is not suggested by the images. The presence of inguinal dissection further confirms that this is not just an orchidectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Debridement:</strong> Debridement is a procedure involving the removal of necrotic or infected tissue to promote wound healing. The images do not show the characteristics of a debridement procedure, such as wound cleansing or preparation for further wound care. Instead, the structured surgical approach seen suggests a more extensive oncologic procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Penectomy with orchidectomy:</strong> This is combined procedure is not commonly done, and doesn’t depict the images provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Penectomy with inguinal dissection is a treatment approach for penile cancer, involving removal of the penis and associated lymph node dissection to manage local and regional disease spread.</span></p>",
      "correct_choice_id": 227929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54967,
      "choices": [
        {
          "id": 219329,
          "text": "<p><span style=\"font-size:12.0pt;\">Myopia</span></p>"
        },
        {
          "id": 219330,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypermetropia</span></p>"
        },
        {
          "id": 219331,
          "text": "<p><span style=\"font-size:12.0pt;\">Presbyopia</span></p>"
        },
        {
          "id": 219332,
          "text": "<p><span style=\"font-size:12.0pt;\">Astigmatism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The corrected refractory error is: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q1396764",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510007,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Presbyopia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The \"corrected\" refractory error, which implies the condition after it has been corrected with appropriate lenses. Presbyopia is unique among the options as it's not a refractive error in the traditional sense, but an age-related condition affecting near vision. When corrected with reading glasses or multifocal lenses, presbyopia allows for clear near vision without altering distance vision, effectively \"correcting\" the inability to focus on near objects.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/28/screenshot-2024-08-28-110104.png\" alt=\"\" width=\"500\" height=\"246\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Myopia:</strong> This is a refractive error where distant objects appear blurry. It's corrected with concave (minus) lenses, not the correction itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypermetropia (Hyperopia): &nbsp;</strong>This condition causes difficulty focusing on near objects and is corrected with convex (plus) lenses, but it's not the corrected state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Astigmatism:</strong> &nbsp;This is an imperfection in the curvature of the eye's cornea or lens, corrected with cylindrical lenses, but again, it's not the corrected state itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Presbyopia is unique among refractive conditions as its correction (typically with reading glasses) results in clear near vision without altering distance vision, effectively achieving a \"corrected\" state for both near and far vision</span></p>",
      "correct_choice_id": 219331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10345,
      "choices": [
        {
          "id": 41346,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 41347,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 41348,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 41349,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following increase the risk of recurrence of febrile seizures? (INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Age &lt; 1 year</span></li><li><span style=\"font-size:12.0pt;\">Temperature of 38-39°C</span></li><li><span style=\"font-size:12.0pt;\">Duration of fever &lt; 24 h</span></li><li><span style=\"font-size:12.0pt;\">Duration of fever &gt; 48 h</span></li></ol>",
      "unique_key": "Q7383663",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509763,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The risk of recurrent febrile seizures is increased in children who are less than 1 year old, have a fever with a temperature between 38-39°C, and have a fever duration of less than 24 hours. Febrile seizures typically occur in children between the ages of 6 and 60 months and are generalized tonic-clonic seizures that occur in the setting of fever without any underlying intracranial infection or a previous history of unprovoked seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Risk Factors:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Age &lt; 1 year:&nbsp;</strong>Younger age increases the likelihood of recurrent febrile seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Temperature of 38-39°C:&nbsp;</strong>Lower fever temperatures (38-39°C) are associated with a higher risk of recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Duration of fever &lt; 24 h:&nbsp;</strong>A shorter duration of fever before the onset of seizures is associated with an increased risk of recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Information:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Minor risk factors&nbsp;</strong>for recurrence include male gender, attending daycare, having complex febrile seizures, a family history of febrile seizures, and lower serum sodium levels at presentation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Duration of fever &gt; 48 hours:&nbsp;</strong>A duration of fever greater than 48 hours is not considered a risk factor for febrile seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The risk of recurrent febrile seizures is increased in children under 1 year of age, with fever temperatures between 38-39°C, and fever lasting less than 24 hours.</span></p>",
      "correct_choice_id": 41348,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54234,
      "choices": [
        {
          "id": 216405,
          "text": "<p><span style=\"font-size:12.0pt;\">JNA</span></p>"
        },
        {
          "id": 216406,
          "text": "<p><span style=\"font-size:12.0pt;\">Allergic rhinitis</span></p>"
        },
        {
          "id": 216407,
          "text": "<p><span style=\"font-size:12.0pt;\">Coagulation disorder</span></p>"
        },
        {
          "id": 216408,
          "text": "<p><span style=\"font-size:12.0pt;\">Antrochoanal polyp</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 13-year-old boy presents with right-sided nasal obstruction and recurrent epistaxis for the past 6 months. What is the most likely diagnosis?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1923438",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510005,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) JNA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Juvenile nasopharyngeal angiofibroma (JNA) is a benign but locally aggressive vascular tumor that occurs almost exclusively in adolescent males. The typical presentation includes nasal obstruction and recurrent episodes of epistaxis (nosebleeds).</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KUsnzTr.png\" width=\"940\" height=\"242\"></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Allergic Rhinitis:</strong> Nasal obstruction but no recurrent epistaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Coagulation Disorder:</strong> Bleeding from multiple sites, not specific to nasal obstruction in adolescent males.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antrochoanal Polyp:</strong> Nasal obstruction without recurrent epistaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Juvenile nasopharyngeal angiofibroma (JNA) is the most likely diagnosis for a 13-year-old boy with right-sided nasal obstruction and recurrent epistaxis, as it commonly presents in adolescent males with these symptoms.</span></p>",
      "correct_choice_id": 216405,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43993,
      "choices": [
        {
          "id": 175631,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA B27</span></p>"
        },
        {
          "id": 175632,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA DR3</span></p>"
        },
        {
          "id": 175633,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA DR4</span></p>"
        },
        {
          "id": 175634,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA DQ8</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which HLA is associated with Reiter’s syndrome? (FMGE JAN 2024)</span></p>",
      "unique_key": "Q5899898",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509758,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) HLA B27</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>REACTIVE ARTHRITIS</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Reactive arthritis (ReA) is <strong>inflammatory arthritis</strong> that manifests after several days to weeks after a <strong>gastrointestinal or genitourinary infection</strong>.</span></li><li><span style=\"font-size:12.0pt;\">It is also described as a classic <strong>triad of arthritis, urethritis, and conjunctivitis</strong>. However, a majority of patients do not present with the classic triad.</span></li><li><span style=\"font-size:12.0pt;\">It is&nbsp;known&nbsp;to be&nbsp;triggered by a <strong>bacterial infection</strong>, particularly of the <strong>genitourinary</strong> (Chlamydia trachomatis, Neisseria gonorrhea, Mycoplasma hominis, and Ureaplasma urealyticum) or <strong>gastrointestinal</strong> (GI) tract (Salmonella enteritidis,&nbsp;Shigella flexneri, and&nbsp;S. disenteriae,&nbsp;Yersinia enterocolitica,&nbsp;Campylobacter jejuni,&nbsp;Clostridium difficile).</span></li><li><span style=\"font-size:12.0pt;\">The incidence is about <strong>2-4% after a urogenital infection</strong>, mainly with&nbsp;Chlamydia trachomatis,&nbsp;and varies from <strong>0-15% after gastrointestinal infections</strong> with&nbsp;Salmonella,&nbsp;Shigella,&nbsp;Campylobacter, or&nbsp;Yersinia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pathophysiology:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Reactive arthritis is an <strong>immune-mediated syndrome</strong> triggered by a recent infection.</span></li><li><span style=\"font-size:12.0pt;\">It is hypothesized that <strong>T lymphocytes</strong> are induced by bacterial fragments such as lipopolysaccharide and nucleic acids when invasive bacteria reach the systemic circulation.</span></li><li><span style=\"font-size:12.0pt;\">These activated cytotoxic-T cells attack the synovium and other self-antigens through molecular mimicry.</span></li><li><span style=\"font-size:12.0pt;\">It is believed that&nbsp;<strong>anti-bacterial cytokine response is also impaired</strong> in reactive arthritis, resulting in decreased bacteria elimination.</span></li><li><span style=\"font-size:12.0pt;\">The prevalence of <strong>HLA-B27</strong> in reactive arthritis is estimated at <strong>30-50%</strong> in patients with reactive arthritis.</span></li><li><span style=\"font-size:12.0pt;\">HLA-B27 should <strong>not be used as a diagnostic tool</strong> for diagnosing acute ReA.</span></li><li><span style=\"font-size:12.0pt;\">The presence of HLA-B27 is believed to <strong>potentiate reactive arthritis</strong> by presenting bacterial antigens to T cells, altering the self-tolerance of the host immune system, increasing tumor necrosis factor-alpha production, promoting the invasion of microbes in the gut, and delaying clearance of causative organisms.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option. B. HLA DR3</strong>: This allele is more commonly associated with other autoimmune conditions, such as type 1 diabetes and systemic lupus erythematosus, rather than with reactive arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option. C. HLA DR4</strong>: This allele is most notably associated with rheumatoid arthritis, especially in individuals who have severe disease forms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option. D. HLA DQ8</strong>: This HLA subtype is also more commonly associated with type 1 diabetes and not typically linked with reactive arthritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HLA-B27 is strongly associated with reactive arthritis (Reiter's syndrome) and other spondyloarthropathies like ankylosing spondylitis, psoriatic arthritis, and enteropathic arthritis.</span></li><li><span style=\"font-size:12.0pt;\">Approximately 75-80% of patients with reactive arthritis test positive for HLA-B27.</span></li><li><span style=\"font-size:12.0pt;\">But it should not be used as a diagnostic tool for acute ReA.</span></li></ul>",
      "correct_choice_id": 175631,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10232,
      "choices": [
        {
          "id": 40894,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 40895,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 40896,
          "text": "<p><span style=\"font-size:12pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 40897,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy should be given to which of the following persons?</span>(INICET NOVEMBER 2022)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Sharing the same clothes, towels</span></li><li><span style=\"font-size:12pt;\">Living with a patient with leprosy for &gt; 6 month</span></li><li><span style=\"font-size:12pt;\">Contact of age more than 2 years</span></li><li><span style=\"font-size:12pt;\">Contact for more than 20 hours per week.&nbsp;</span></li></ol><p>&nbsp;</p>",
      "unique_key": "Q6839710",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509778,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy should be given to contacts 2, 3 and 4.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Chemoprophylaxis for leprosy should be given to the following contacts:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Being identified as a contact, i.e., a person who has been in close contact with the index case for <strong>20 hours (option 4) or more per week for more than 3 months</strong> <strong>(option 2)</strong> (Exception is <strong>blanket approach</strong> where no link with an index case needs to be established.)</span></li><li><span style=\"font-size:12pt;\"><strong>Age:</strong>&nbsp;<strong>More than 2 years (option 3);</strong> if younger than 2 years, the child can be given SDR at the age of 2, in follow up visits of contacts (if meeting all other inclusion criteria.)</span></li><li><span style=\"font-size:12pt;\"><strong>Consent of the contact obtained</strong>. Depending on the country situation, this can be <strong>written</strong> or a <strong>verbal consent</strong>. In case of children, consent should be obtained from the <strong>parent</strong> or <strong>guardian,</strong> and sometimes an <strong>assent</strong> from the <strong>grown-up</strong> <strong>children.</strong></span></li><li><span style=\"color:#0f0f0f;font-size:12pt;\"><strong>Sharing&nbsp;</strong>the same <strong>clothes and</strong> <strong>towels (Option 1),</strong> while a potential <strong>route of transmission</strong>, is <strong>not</strong> generally considered a primary <strong>criterion</strong> for <strong>chemoprophylaxis.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Exclusion criteria</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">Persons with possible signs and/or symptoms of <strong>leprosy;</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Persons with possible signs and/or symptoms of <strong>TB</strong> <strong>or confirmed with TB;</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Persons with a history of <strong>liver or kidney disorders</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Pregnancy</strong>; SDR can be <strong>given after the delivery</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\">Persons who have received <strong>rifampicin in the last two years</strong> e.g. as treatment of TB, leprosy or as prophylaxis (e.g. contact of another index case);</span></li><li><span style=\"color:black;font-size:12pt;\">Persons with history of <strong>allergy to rifampicin</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Refusal to take SDR.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy is crucial for contacts who have had significant exposure to an individual with leprosy, particularly those living in the same household or in close contact for extended periods.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Rifampicin:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A <strong>single dose of 600 mg</strong> kills more than <strong>99%</strong> of the <strong>susceptible organisms</strong> present at the start of treatment, that is as much as <strong>3 to 6 months</strong> of daily treatment with the combination <strong>dapsone plus Clofazimine.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Rifampicin&nbsp;</strong>has become established as a <strong>highly potent bactericidal drug</strong>, and it acts by <strong>inhibiting</strong> the <strong>bacterial DNA dependent RNA polymerase</strong>.</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Single Dose of Rifampicin&nbsp;</strong>(SDR) is used in <strong>chemoprophylaxis.</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Chemoprophylaxis must be initiated only <strong>4 weeks after treatment for leprosy</strong> has begun in the <strong>patient</strong> so as to ensure the <strong>patient is non-infectious</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><i><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-160933.jpg\" alt=\"\" width=\"1000\" height=\"405\"></i></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref -&nbsp;</strong></span><span style=\"color:black;font-size:12pt;\"><strong>Jopling’s Handbook of Leprosy 6<sup>th</sup> Edition Page no 242</strong></span></p><p><span style=\"color:#3c4245;font-size:12pt;\"><strong>Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis</strong></span></p><p><a href=\"https://www.who.int/publications/i/item/9789290228073\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/publications/i/item/9789290228073</u></strong></span></a><span style=\"font-size:12pt;\"><strong> (page 23, 24)</strong></span></p><p><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/\"><span style=\"font-size:12pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/</u></strong></span></a></p>",
      "correct_choice_id": 40896,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10410,
      "choices": [
        {
          "id": 41606,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alpha-1-antitrypsin deficiency</span></span></span></p>"
        },
        {
          "id": 41607,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystic fibrosis</span></span></span></p>"
        },
        {
          "id": 41608,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mutation in dynein arms</span></span></span></p>"
        },
        {
          "id": 41609,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibodies against type-IV collagen</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman with a long history of dyspnea, chronic cough with sputum, and wheezing died of respiratory failure following a bout of lobar pneumonia. She was not a smoker or an alcoholic. The lung at autopsy is shown in the image below. Which of the following is most likely to cause the pathological changes shown? (NEET PG 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/51_FGt3kor.jpg\" style=\"height:184px; width:274px\" /></span></span></span></p>",
      "unique_key": "Q3381963",
      "question_audio": null,
      "question_video": null,
      "map_id": 20510004,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Alpha-1-antitrypsin deficiency&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The gross specimen shown above has emphysematous damage involving enlargement of the entire acinus, indicating panacinar emphysema. It is caused by a lack of alpha-1-antitrypsin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The acini in this type are uniformly enlarged from the respiratory bronchiole to the terminal blind alveoli. The prefix &quot;pan&quot; denotes the <strong>entire acinus</strong> but not the entire lung. Panacinar emphysema, as opposed to centriacinar emphysema, <strong>is more common in the lower zones and anterior margins</strong> of the lung, and it is usually <strong>most severe at the bases</strong>. This type of emphysema is linked to a lack of alpha 1-antitrypsin (AT).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/52_iCjo3wK.jpg\" style=\"height:446px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/53_WFL7eVf.jpg\" style=\"height:171px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">, Centriacinar emphysema. Central areas show marked emphysematous damage (E), surrounded by relatively spared alveolar spaces. <strong>B</strong>, Panacinar emphysema involving the entire pulmonary lobule.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cystic fibrosis: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pathology:</span></strong><span style=\"font-size:12.0pt\"> Cystic fibrosis is characterized by thick, sticky mucus production leading to recurrent lung infections and bronchiectasis, not emphysema.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Etiology:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Caused by mutations in the CFTR gene, leading to defective chloride channels.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mutation in dynein arms:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pathology:</span></strong><span style=\"font-size:12.0pt\"> Dynein arm mutations are associated with primary ciliary dyskinesia (PCD), which leads to impaired mucociliary clearance and recurrent respiratory infections, but not typically emphysema.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antibodies against type-IV collagen: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pathology:</span></strong><span style=\"font-size:12.0pt\"> Associated with Goodpasture syndrome, which causes pulmonary hemorrhage and glomerulonephritis, not emphysema.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alpha-1-antitrypsin deficiency is a genetic disorder leading to a lack of AAT, which protects the lung tissue from elastase. The deficiency causes panacinar emphysema, characterized by uniform enlargement of acini, particularly in the lower lobes of the lung, and presents with chronic respiratory symptoms.</span></span></span></p>",
      "correct_choice_id": 41606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11998,
      "choices": [
        {
          "id": 47956,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 47957,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 47958,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 47959,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are signs of heart failure? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Non-pulsatile rise of JVP</span></li><li><span style=\"font-size:12.0pt;\">Orthopnea</span></li><li><span style=\"font-size:12.0pt;\">Dyspnea after 2 hours of sleep</span></li><li><span style=\"font-size:12.0pt;\">Right upper quadrant pain/Right hypochondrial pain</span></li></ol>",
      "unique_key": "Q8333240",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509770,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Heart failure presents with a range of symptoms due to the inability of the heart to pump blood effectively. The following signs are indicative of heart failure:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Orthopnea (Option 2):</strong> This is difficulty breathing when lying flat and is a common symptom of left-sided heart failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dyspnea after 2 hours of sleep (Option 3):</strong> Also known as paroxysmal nocturnal dyspnea (PND), this occurs due to fluid redistribution during sleep, leading to pulmonary congestion.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Right upper quadrant pain/Right hypochondrial pain (Option 4):</strong> This is associated with right-sided heart failure leading to congestive hepatomegaly.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option 1 (Non-pulsatile rise of JVP):</strong> This is incorrect as heart failure typically causes a pulsatile rise in jugular venous pressure (JVP). A non-pulsatile rise in JVP is usually indicative of superior vena cava (SVC) obstruction, not heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Signs of heart failure include orthopnea, paroxysmal nocturnal dyspnea (PND), and right upper quadrant pain due to congestive hepatomegaly.</span></p>",
      "correct_choice_id": 47957,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54906,
      "choices": [
        {
          "id": 219085,
          "text": "<p><span style=\"font-size:12.0pt;\">Nomophobia</span></p>"
        },
        {
          "id": 219086,
          "text": "<p><span style=\"font-size:12.0pt;\">Acrophobia</span></p>"
        },
        {
          "id": 219087,
          "text": "<p><span style=\"font-size:12.0pt;\">Claustrophobia</span></p>"
        },
        {
          "id": 219088,
          "text": "<p><span style=\"font-size:12.0pt;\">Agoraphobia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An individual experiences intense fear and anxiety when confronted with tall structures and the prospect of looking down from great heights. Which term best describes this condition? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q7032835",
      "question_audio": null,
      "question_video": null,
      "map_id": 20509780,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Acrophobia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acrophobia is the fear of heights. This condition causes individuals to experience intense fear and anxiety when they are at a significant height or even when they think about being in such a situation. This fear can be triggered by standing on a tall structure or looking down from a height, and it often leads to avoidance of high places.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nomophobia:&nbsp;</strong>This is <strong>the fear of being without a mobile phone</strong> or losing signal on a mobile device.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Claustrophobia:&nbsp;</strong>This refers to the <strong>fear of confined or closed spaces</strong>, such as elevators or tight rooms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Agoraphobia:&nbsp;</strong>This is the <strong>fear of places or situations where escape might be difficult</strong>, such as <strong>crowded places or open spaces</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acrophobia is the term used to describe the fear of heights, a common phobia that can cause significant distress and avoidance behavior in individuals.</span></p>",
      "correct_choice_id": 219086,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}